Harmony Biosciences Holdings, Inc.
HRMY • NASDAQ • Stock Fundamentals
Harmony Biosciences Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey Dayno, with a market cap of $2.0B.
Market Cap$2.0B
Employees246.0
CEOJeffrey Dayno
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Harmony Biosciences Holdings, Inc. FAQ
Common questions about Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) has a market capitalization of $2.0B and trades on NASDAQ.
Harmony Biosciences Holdings, Inc. has approximately 246 employees.